Skip to main content

Closed

IBO: Impact BioMedical Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-98.0% / yr

Operating margin-11782.1%

ROIC-24.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-8.8×

Current ratio0.22×

Impact BioMedical Inc.

IBONew York Stock Exchange Arca·USD·Closed

Impact BioMedical Inc.

IBONew York Stock Exchange Arca·USD·Closed

$0.44

+0.23%

$0.44

+$0.00 (0.23%)

52W Range

15thpctl

Volume

1.83×avg

Mkt Cap

5.50MUSD

P/E

-0.3TTM

Div Yield

–ann

52W Range

15thpctl

Volume

1.83×avg

Market Cap

5.50MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings